Co-Diagnostics has entered an agreement with its joint venture partner CoSara Diagnostics to expand its commercial and ...

Rapid near-point-of-care molecular tests using tongue swabs can help end TB, enabling diagnosis and treatment to begin within ...

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent ...

Co-Diagnostics inks agreement with CoSara Diagnostics to expand commercial and distribution territory across South Asia: Salt Lake City Monday, March 23, 2026, 12:00 Hrs [IST] Co- ...

Co-Diagnostics Inc. on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd, to expand its commercial and distribution ...

A new HRM PCR approach can track the spread of leishmaniasis, a parasitic disease affecting both animals and humans.

In oncology care, respiratory can pose serious risks—especially when diagnostic delays disrupt treatment decisions. Yet many ...

Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent: Salt Lake City Friday, March 13, 2026, 15:00 Hrs [IST] Co-Diagnostics, Inc., (Co-Dx), a molecular diagn ...

Discover the principles behind Countable PCR, how it compares with established molecular quantification methods, and what direct RNA counting could mean for research and clinical applications.

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced four ...